ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Feb 29, 2016
Dividend Increases/Decreases for the Week Ending February 26
Let's take a look at companies raising their dividends this week.
Feb 26, 2016
Defense Dividends Remain Solid; Little Valuation Opportunity Present
Major defense players reported a mixed bag of results in the fourth quarter of 2015, but there are a few consistencies across the space: competition is strong, dividends remain solid, and valuations are full.
Feb 23, 2016
Recent Add Cracker Barrel Surges Ahead; BHP Cuts
We liked what we heard in Cracker Barrel’s outlook, and the Dividend Cushion ratio again comes up big in warning about BHP’s dividend cut.
Feb 22, 2016
Key Treatment Momentum Drives Big Pharma
Let’s take a look at the recent results of some of the biggest names in Big Pharma.
Feb 22, 2016
Dividend Increases/Decreases for the Week Ending February 19
Let's take a look at companies raising their dividends this week.
Feb 21, 2016
Growing Cautious on Teva Pharma
Best Ideas Newsletter portfolio holding Teva Pharmaceuticals reported a disappointing fourth quarter.
Feb 17, 2016
Feb 16, 2016
We Like the News! Buffett Scoops Up Kinder Morgan; FVE: $20
Let’s talk about the market action February 16.
Feb 14, 2016
Dividend Increases/Decreases for the Week Ending February 12
Let's take a look at companies raising their dividends this week.
Feb 12, 2016
Your Hard-Earned Money
Valuentum is releasing its February Best Ideas Newsletter early, February 12, in light of Presidents’ Day weekend.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.